Benefits of switching postmenopausal women with hormone-sensitive early breast cancer to anastrozole after 2 years adjuvant tamoxifen: combined results from 3 123 women enrolled in the ABCSG Trial 8 and the ARNO Trial 95. - Kaufmann,M.; Jakesz,R.; Gnant,M. (The Breast, 2005)